hyperparathyroidism shariati thursday conference 86 12 16

43
HYPERPARATHYROIDISM HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Upload: allan-horton

Post on 06-Jan-2018

227 views

Category:

Documents


4 download

DESCRIPTION

Biochemistry  Parathyroid Glands (4 glands 6*3*2 mm.)  84 aa protein (9500 D)  Receptor in target cell (osteoblast, osteoclast, renal tubules)  cAMP enzym release reaction catalysis

TRANSCRIPT

Page 1: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

HYPERPARATHYROIDISMHYPERPARATHYROIDISM

Shariati Thursday Conference86 12 16

Page 2: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

ParaThyroid Hormone (PTH) Biochemistry Physiology pathophysiology

Hyperparathyroidism Clinical manifestation Diagnosis

◦Lab finding◦ imaging

treatment

Page 3: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Biochemistry

Parathyroid Glands (4 glands 6*3*2 mm.)

84 aa protein (9500 D)

Receptor in target cell (osteoblast, osteoclast, renal tubules)

cAMP enzym release reaction catalysis

Page 4: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Physiology

GI intake

Urinary out put

Bone

PTHVit DCalcitonin

GISweat

Page 5: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

GI intake

Urinary out put

Bone

GISweat

Physiology

400-1000mg

10-70%

100-300mg>4mg/kg abn.

7g98%

Vit D

Page 6: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

GI intake

Urinary out put

Bone Ca

GISweat

Physiology

.

99%=1-2kg

Intra cellular Ca 0.1%

1%Pr.Bound Ca 40%Non-ionized Ca 10%Ionized Ca 40%

Page 7: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Bone Ca

Kidney Ca

GI Ca

In minutes Osteocyt&blast

In days Osteoclast

Page 8: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology◦Primary hyperpara◦Secondary hyperpara◦Tertiary hyperpara

◦pseudohyperpara

Page 9: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology◦Primary hyperpara

◦Diffiuse hyperplasia 10-40%◦Single adenoma 50-80%◦Multiple adenoma 10%◦Carcinoma 1%

◦Secondary hyperpara◦Tertiary hyperpara

◦pseudohyperpara

Page 10: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology◦Primary hyperpara◦Secondary hyperpara

◦Secondary to hypocalcemia Renal dysfunction P Malabsorption P

◦Tertiary hyperpara

◦pseudohyperpara

Page 11: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology◦Primary hyperpara◦Secondary hyperpara◦Tertiary hyperpara

◦Autonomus hyperactivity after secondary hyperpara

◦pseudohyperpara

Page 12: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology◦Primary hyperpara◦Secondary hyperpara◦Tertiary hyperpara

◦pseudohyperpara ◦Hypercalcemia of malignancy

without metastasisor primary hyperpara

Page 13: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology◦Primary hyperpara Ca / N ◦Secondary hyperpara Ca / N◦Tertiary hyperpara

◦pseudohyperpara

Page 14: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Pathophysiology

◦Osteoclast/Osteoblast

◦Osteoclast activity◦Osteoblast activity

◦Remodeling activity

Page 15: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Clinic

100,000 new case / year in USA 1/1000

4th and 6th decade F/M = 2/1

Page 16: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Clinical findings:

◦Renal◦Gastrointestinal◦Skeletal manifestation

◦CNS◦Skin◦Cardiovascular

◦hypercalcaemia

common

rare

nowadays

Page 17: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Renal Urinary tract calculi Nephrolithiasis

Gastrointestinal Peptic ulcer Pancreatitis

Skeletal 10-25% Tenderness Aching pain (peripheral joints & vertebrae) Sever pain, swelling, deformity

Page 18: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Rare manifestations:

CNSPersonal disturbance, coma, fatigue

SkinDry skin, itching

CardiovascularHypertension, CHF

Page 19: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Lab exam,

◦Ca◦P◦Alk Ph.◦Urin Ca

Page 20: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Lab exam,

◦Ca PrimaryUp-N Secondary N-Low

Total Ca 50% ionic calcium (acidosis, hypoproteinemia)◦P◦Alk Ph.◦Urin Ca

◦PTH

Page 21: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Lab exam,

◦Ca◦P

◦Primary Low◦Secondary Up/Low

◦Alk Ph.◦Urin Ca

◦PTH

Page 22: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Lab exam,

◦Ca◦P◦Alk Ph.

◦Hyperphosphatesia

◦Urin Ca

◦PTH

Page 23: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Lab exam,

◦Ca◦P◦Alk Ph.◦Urin Ca.

◦Hypercalciurea

◦PTH

Page 24: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Lab exam,

◦Ca◦P◦Alk Ph.◦Urin Ca.

◦PTH ◦Up ◦Rarely N

Page 25: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Radiologic findings,

◦Bone resorption

◦Bone survey Bone resorption of hand is highly sensitive If

high qualitymacroradiography/digitalized radiograhy

◦Bone densitometry

Page 26: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Radiologic findings,

◦Bone resorption

◦Bone survey Bone resorption of hand is highly sensitive If

high qualitymacroradiography/digitalized radiograhy

◦Bone densitometry

Page 27: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Bone resorption Subperiosteal Juxtaarticular Intraarticular, (high turn over, hyperthyroidism) Subchondral Endosteal, (MM, Osteoporosis) Subphysial Trabecular Sublig. And sub tendinous Brown tumor

Page 28: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Bone resorptionSubperiosteal Juxtaarticular Intraarticular, (high turn over, hyperthyroidism) Subchondral Endosteal, (MM, Osteoporosis) SubphysialTrabecular Sublig. And sub tendinousBrown tumor

Page 29: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperiosteal resorption

Diagnostic (prominent) DD: chronic renal disease Radial aspect of the hand phalanx

Middle phalanx Index & middle finger

Page 30: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperioseal resorption

Progressive

lace like appearance

Page 31: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperioseal resorption

Progressive

lace like appearance

speculated contour

Page 32: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperioseal resorption

Progressive

lace like appearance

speculated contour

complete resorption of cortex

Page 33: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperiosteal resorption

Other sites; Phalanx tuft Medial proximal tibia, femur,humerus Upper and lower border of the rib Lamina dura

Subperiosteal resorption

Other sites; Phalanx tuft Medial proximal tibia, femur,humerus Upper and lower border of the rib Lamina dura

Page 34: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperiosteal resorption

Phalanx tuft, acro-osteolysis

Page 35: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperiosteal resorption

Phalanx tuft, acro-osteolysis

Page 36: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Subperiosteal resorption

Phalanx tuft, acro-osteolysis

Page 37: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Trabecular resorption

Medullary bone In advance stages Granular appearance

In cranium is caractristic osteopenia+speckled appear=Salt and Pepper

Page 38: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Trabecular resorption

Page 39: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Brown tumor

Osteoclastoma Specially in primary hyperpara

Fibrous tissue+giant cells

Radiologic app.◦Single or multiple◦Well defined◦Axial or appendicular skeleton◦Cortical or eccentric◦Could be expansile◦Common sites; face bones, pelvis, rib, femur

Page 40: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Brown tumor

Usually after other signs Occasionally as presenting finding

Page 41: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Diagnosis

◦Lab exam Ca PTH

◦Preoperative study Tc labeled Sestamibi

Page 42: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Treatment

◦Surgery

◦Adenoma resection◦Resection of 3.5 gland

◦Post operative care

Page 43: HYPERPARATHYROIDISM Shariati Thursday Conference 86 12 16

Thank you for your attention